Arena Withdraws Application for Weight-Loss Drug Approval in Europe
Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States ...Read Full Story »








